Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?

Detalles Bibliográficos
Autores principales: Hida, Toyoaki, Yamaguchi, Teppei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475526/
https://www.ncbi.nlm.nih.gov/pubmed/32944372
http://dx.doi.org/10.21037/jtd-20-1672
_version_ 1783579524806475776
author Hida, Toyoaki
Yamaguchi, Teppei
author_facet Hida, Toyoaki
Yamaguchi, Teppei
author_sort Hida, Toyoaki
collection PubMed
description
format Online
Article
Text
id pubmed-7475526
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-74755262020-09-16 Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy? Hida, Toyoaki Yamaguchi, Teppei J Thorac Dis Editorial Commentary AME Publishing Company 2020-08 /pmc/articles/PMC7475526/ /pubmed/32944372 http://dx.doi.org/10.21037/jtd-20-1672 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial Commentary
Hida, Toyoaki
Yamaguchi, Teppei
Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title_full Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title_fullStr Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title_full_unstemmed Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title_short Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
title_sort advances in immunotherapy for stage iii non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy?
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475526/
https://www.ncbi.nlm.nih.gov/pubmed/32944372
http://dx.doi.org/10.21037/jtd-20-1672
work_keys_str_mv AT hidatoyoaki advancesinimmunotherapyforstageiiinonsmallcelllungcancermovingimmunecheckpointinhibitorstothefrontlinesconcurrentlywithchemoradiotherapy
AT yamaguchiteppei advancesinimmunotherapyforstageiiinonsmallcelllungcancermovingimmunecheckpointinhibitorstothefrontlinesconcurrentlywithchemoradiotherapy

Ejemplares similares